Table 4 Comparison of clinical characteristics of patients with re-fractures with different comorbidities

L1-4BMD (g/cm²)

0.893 ± 0.144

0.852 ± 0.149

0.166

0.836 ± 0.134

0.865 ± 0.154

0.188

0.881 ± 0.170

0.856 ± 0.148

0.523

0.850 ± 0.147

0.858 ± 0.149

0.845

Total hip BMD (g/cm²)

0.734 ± 0.123

0.712 ± 0.134

0.412

0.680 ± 0.131

0.728 ± 0.132

0.016*

0.724 ± 0.100

0.714 ± 0.135

0.789

0.679 ± 0.099

0.717 ± 0.135

0.317

Femoral neck BMD (g/cm²)

0.684 ± 0.101

0.664 ± 0.117

0.360

0.632 ± 0.112

0.679 ± 0.115

0.006*

0.662 ± 0.092

0.667 ± 0.117

0.869

0.621 ± 0.067

0.669 ± 0.117

0.140

Serum BGP (ng/mL)

14.753 ± 6.202

20.416 ± 8.340

0.000*

20.892 ± 10.384

19.248 ± 7.406

0.185

20.671 ± 4.750

19.608 ± 8.513

0.622

18.149 ± 5.735

19.773 ± 8.434

0.495

Serum CTX (pg/mL)

344.693 ± 209.605

482.494 ± 219.751

0.001*

472.053 ± 224.535

461.922 ± 222.922

0.761

529.319 ± 254.836

459.781 ± 220.257

0.229

379.754 ± 168.659

469.657 ± 225.035

0.158

Serum Ca (mmol/L)

2.281 ± 0.108

2.271 ± 0.129

0.699

2.282 ± 0.164

2.269 ± 0.110

0.571

2.287 ± 0.135

2.271 ± 0.126

0.634

2.235 ± 0.101

2.275 ± 0.127

0.268

Serum P (mmol/L)

1.225 ± 0.181

1.192 ± 0.151

0.280

1.174 ± 0.135

1.204 ± 0.162

0.189

1.251 ± 0.130

1.192 ± 0.157

0.148

1.165 ± 0.178

1.198 ± 0.154

0.449

Serum PTH (pg/mL)

42.115 ± 19.887

47.155 ± 22.561

0.248

49.945 ± 31.054

45.264 ± 18.055

0.270

44.888 ± 22.013

46.620 ± 22.321

0.765

52.269 ± 17.064

46.156 ± 22.513

0.337

Serum 25OHD (nmol/L)

53.134 ± 19.276

51.429 ± 20.246

0.493

52.884 ± 22.657

51.384 ± 19.160

0.618

63.004 ± 29.941

50.945 ± 19.010

0.132

44.052 ± 23.617

52.241 ± 19.841

0.154